Nanotoday Thursday, 08/27/15 10:36:52 AM Re: leifsmith post# 114766 Post # of 145298 The claim wasn't that Ebolacide 2 testing was sure to result in a completely successful test of a viricide against Ebola. The claim was that there was very ilttle risk in doing the testing. What many (including myself) claimed was that failure of Ebolacide would put the entire platform in question, and make company claims about rapid response and ease of new treatment development suspect. I believe that is exactly what happened and is certainly part of the decline from the time your trusted associate made the claim until now. From $3 to under a buck.